ICAM1 and B-cell chronic lymphocytic leukemia: To determine whether disease activity, treatment, IGHV mutational status, Binet stage, blood number counts, and percentage of CLL cells affect the expression level of investigated markers on neutrophils, we compared the expression of CD54, CD11b, CD62L, and CD64 in CLL subgroups.